StemCells, Inc. is currently engaged in clinical development of its proprietary HuCNS-SC® (purified human neural stem cells) platform technology to treat diseases of the human central nervous system (CNS).
Our Mission is to address unmet medical needs through the use of novel cell-based therapeutics that hold the promise of better treatments and cures. We are guided by an unwavering commitment to excellence, integrity and innovation as we strive to help improve health and well-being worldwide.
Our Vision is to transform medicine by fulfilling the therapeutic promise of human neural stem cells — as a one-time intervention yielding a long-term benefit for millions of patients suffering from the devastating effects of intractable diseases and disorders of the central nervous system.
Driven by more than 20 years of pioneering research and innovation, StemCells, Inc. is a recognized leader when it comes to expertise, scientific achievement and intellectual property in the field of stem cell biology
StemCells, Inc. is applying its scientific and industry leadership to address unmet medical needs through the development of stem cells as therapeutic agents to treat damage to or degeneration of the three components of the CNS: the brain, the spinal cord and the eye.